Omeros Corp. shares rose 17% in premarket trade Friday after the company reported a third-quarter revenue beat and a narrower-than-expected profit loss. The company reported a loss of $7.48 million, or a loss of 16 cents per share, after a loss of $13.96 million, or a loss of 34 cents per share in the year-earlier period. The FactSet earnings-per-share consensus was a loss of 33 cents. Revenue rose to $21.66 million from $11.29 million, compared with the FactSet consensus of $17.8 million. The latest results included a 26% increase in revenue from its key product Omidria, which is used in certain eye surgeries, from the prior quarter and a 92% rise from the year-earlier period. Omeros shares have plummeted 40.2% over the last three months to $14.09, compared with a 6% surge in the S&P 500 and a 7.4% rise in the Dow Jones Industrial Average .
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News